Project supported by the Naturual Science Foundation of Shandong Province, No. 91C0428.
Published online Jun 15, 1998. doi: 10.3748/wjg.v4.i3.238
Revised: March 25, 1998
Accepted: May 2, 1998
Published online: June 15, 1998
AIM: To observe the effect of octreotide (OT) and somatostatin (SS) on gallbladder pressure and myoelectric activity of SO in rabbits.
METHODS: Male rabbits fasted for 15 h-18 h and anesthetized with urethane. The mean gallbladder pressure (GP) and myoelectric activity of SO were simutaneously measured with a frog bladder connected to a transducer and a pair of copper electrodes.
RESULTS: After injection of OT (10 μg/kg, iv), the GP decreased in 2 min and reached the lowest value in about 60 min (P < 0.01, n = 19), and completely or partially returned to the normal level in 120 min. The frequency of myoelectric activty of SO was reduced, even disappeared in 2 min (P < 0.01, n = 19) and returned to normal in about 20 min. Injection of SS (10 μg/kg, iv) also decreased GP and myoelectric activity of SO (P < 0.01, n = 7); Before and after injection of OT or SS, injection of CCK-8 (100 ng or 200 ng) caused similar increase in myoelectric activity of SO and GP (P > 0.05). Before and after injection of OT, there were no significant differences in increases of myoelectric activity of SO and GP caused by electric stimulation of dorsal motor nucleus of vagus (P > 0.05).
CONCLUSION: OT and SS decreased GP and myoelectric activity of SO, demonstrating that effects of OT were similar to those of SS. Intravenous injection of OT did not affect the increase of myoelectric activity of SO and GP caused by CCK-8 or electric stimulation of dorsal motor nucleus of vagus.
- Citation: Zhou JH, Liu CY, Zhang RH, Wang HR, Liu KJ. Effects of octreotide on gallbladder pressure and myoelectric activity of Oddi sphincter in rabbits. World J Gastroenterol 1998; 4(3): 238-241
- URL: https://www.wjgnet.com/1007-9327/full/v4/i3/238.htm
- DOI: https://dx.doi.org/10.3748/wjg.v4.i3.238
Octreotide (OT) is an 8 amino acids synthetic analog of somatostatin (SS). Treatment with OT in acromegaly is effective but leads to gallstone formation. OT injections inhibit gallbladder contraction in acromegalic patients[1,2] and normal subjects, stimulating human sphincter of Oddi (SO) activity, which may impair bile evacuation. However, studies of SS, especially effect of OT on motor function of biliary system in animals are scarce and controversial. The aim of this study was to observe the effects of OT and SS on gallbladder pressure (GP) and myoelectric activity of SO in rabbits.
Thirty-eight male rabbits, weighing 2 kg-2.5 kg were used. They were fasted for 15 h-18 h with free intake of water and then anesthetized with urethane (1.0 g/kg, iv). A cannula was inserted into trachea and the unilateral femoral artery was cathered for the blood pressure measurement.
A frog bladder perfused with saline was placed into the gallbladder and connected to a transducer (TP-200T). A pair of copper electrodes was inserted into subsera of SO. Blood pressure, GP and myoelectric signals of SO were simutaneously measured by a polygrapher (RM-6000, NIHON KHODEN).
OT, cholecystokinin octapeptide (CCK-8) and SS were injected through ear vein. SS and CCK-8 were products of Sigma Chemical Company (St. Louis, U.S.A.) and Pennisula Laboratories (Belmont, U.S.A.) respectively. OT was produced by the Sandoz Pharm Ltd (Besel, Switzerland).
The animal’s head was fixed in a sterotaxic instrument (I-C model, Jiang Wan, China) A wire electrode was inserted into DMV for stimulation (0.2 mA, 10 Hz, 0.5 ms duration, 1 min) according to Messen’s method. An indifferent electrode was placed on the skin tissure of skull.
The constant mean GP of each animal was taken as control level (i.e., basic GP served as 0 kPa in place of the real value) and the frequency of myoelectric activity of SO was considered as normal value. The percentage of frequency changes = (effect value-normal value) ÷ normal value × 100%. All values were expressed as x-±sx-. Experimental data were treated statistically by Student’s t test.
Intravenous injection of OT caused dose-dependent decrease of GP. After injection of OT (10 μg/kg, iv), the GP decreased in 2 min (-0.142 kPa ± 0.029 kPa, P < 0.01) and reached the lowest value in 60 min (-0.257 kPa ± 0.065 kPa, P < 0.01), and completely or partially returned to the normal level in 120 min. Small dose of OT (5 μg/kg, iv), also decreased GP (P < 0.01) but the effect was slight. No change in GP was found after injection of 1ml of 0.9% saline (P > 0.05). The differences were significant (P < 0.01) (Figure 1, Table 1) between the two groups of OT.
|Groups||n||Changes in gallbladder pressure (basic pressure = 0 kPa)|
|± 0.020||± 0.024||± 0.024||± 0.032||± 0.024||± 0.024||± 0.024||± 0.040|
|(5 μg/kg)||± 0.012||± 0.023||± 0.024||± 0.050||± 0.062||± 0.052||± 0.038||± 0.031|
|(10 μg/kg)||± 0.020||± 0.052||± 0.034||± 0.052||± 0.065||± 0.048||± 0.036||± 0.042|
|(10 μg/kg)||± 0.034||± 0.037||± 0.021||± 0.036||± 0.028|
After injection of OT (10 μg/kg, iv), the frequency of myoelectric activity of SO was reduced, even disappeared in 2min (-83.1% ± 8.0%, P < 0.01) and returned to normal in about 20 min. At the dose of 5 μg/kg of OT, frequency of myoelectric activity of SO also decreased (-54% ± 6.1%, P < 0.01). In contrast to OT 10 μg/kg group, the effect is weak (P < 0.05). Injection of the same volume of 0.9% saline influenced neither GP nor myoelectric activity of SO (Figure 1, Figure 2, Table 2).
|Groups||n||Changes in frequency of myoelectric activity of SO (%)|
|± 8.2||± 6.5||± 5.0||± 11.0||± 6.0||± 6.0||± 8.2||± 5.0|
|(5 μg/kg)||± 6.1||± 11.9||± 9.0||± 10.0||± 6.0||± 6.5||± 4.5||± 5.3|
|(10 μg/kg)||± 8.0||± 11.3||± 9.3||± 6.2||± 9.1||± 7.0||± 5.0||± 8.5|
|(10 μg/kg)||± 11.0||± 14.0||± 14.0||± 18.8||± 9.0|
Ten minutes before and 15 min after injection of OT (10 μg/kg, iv), and CCK-8 (100 ng) there was a marked increase in GP and myoelectric activity of SO. Before and after injection of SS (10 μg/kg), and CCK-8 (200 ng) greatly increased GP and myoelectric activity of SO. These responses to CCK-8 showed no significant differences between pre- and post-injection of OT or SS (P > 0.05), (Figure 4, Table 3).
|Group||n||Changes of frequency of myoelectric activity of SO (%)||Changes in gallbladder pressure (basic pressure = 0 kPa)|
|DMV OT||10||283.8 ± 69.6||285.8 ± 75.8||0.128 ± 0.046||0.123 ± 0.031|
|CCK-8 (100 ng) OT||12||346.8 ± 79.2||275.8 ± 37.7||0.363 ± 0.113||0.321 ± 0.112|
|CCK-8 (200 ng) SS||4||485.8 ± 78.9||426.4 ± 59.0||1.795 ± 0.468||1.955 ± 0.340|
Ten minutes before and after injection of OT (10 μg/kg, iv), electric stimulation of DMV increased GP, frequency and amplitude of myoelectric activity of SO, the effects being similar (P > 0.05), (Table 3).
Several studies of SS effect on biliary motility have been reported but the results are different. SS has no effect on contraction of gallbladder smooth muscle strips in guinea pigs, dogs and rabbits, but inhibits gallbladder motility in human and dogs in vivo. SS has been reported to either stimulate or inhibit the SO of dogs[8,9]. In the present study, SS decreased both GP and myoelectric activity of SO. The latter response was similar to the inhibitory SS effect on SO in rabbits reported before. OT, a long-acting analog of SS, has been found to inhibit human gallbladder motility and to stimulate SO contraction which may impair bile evacuation with a risk of gallstone formation[1,2,4]. The animal experiment of OT effect was only conducted on prairie dogs in which OT decreased the motility index of SO, but did not affect the gallbladder pressure. In the present study, OT decreased GP and myoelectric activity of SO in rabbits. These results were consistent with those of SS, demonstrating that inhibitory effect of OT is similar to that of SS. The diverse effects of SS and OT on motility of SO and gallbladder may be explained by the species difference.
The motility of gallbladder and SO is regulated by both autonomic nervous system and intestinal hormones. CCK is an important hormone for mediating motility of biliary tract. In the experiments on dogs, SS inhibits contraction of gallbladder strips induced by electric stimulation and decreased GP by CCK-8 in vivo probably through suppressing Ach release by the intrinsic cholinergic neurons, but does not affect contraction of gallblader strips intiated by Ach or CCK. Intravenous injection of SS inhibits contraction of human gallblader in response to CCK. In our study, injection of CCK-8 markedly raised GP and increased myoelelctric activity of SO in rabbits. After injection of OT or SS, and CCK-8 resulted in increases of GP and myoelectric activity of SO, indicating that SS and OT do not affect the stimulatory effect of CCK-8 on gallbladder and SO. It is reported that electric stimulation of DMV raises GP and increases myoelectric activity of SO through a cholinergic mechanism of vagal nerve. In this study, before and after injection of OT, electric stimulation of DMV caused similar increases in GP and myoelectric activity of SO. These results imply that OT did not inhibit the increase in motility of gallbladder and SO caused by DMV stimulation. The mechanisms of OT effect on motor function of biliary tract require further investigations.
In conclusion, OT and SS decrease GP and myoelectric activity of SO, demonstrating that the inhibitory effect of OT is similar to that of SS in rabbits. Before and after injection of OT and SS, and CCK-8 injection or electric stimulation of DMV similar increases are caused in GP and myoelectric activity of SO, suggesting that OT and SS do not affect the increases in motility of gallbladder and SO caused by CCK-8 and electric stimulation of DMV.
The authors thank Professor LIU Jing-Zhang for his kind help.
|1.||Zhu XF, Shi YF, Zhang JX, Dai Q, Harris AG. Prospective study of long-term therapeutic and wide effects on gallbladder function in Chinese acromega-lic patients. Chin J Int Med. 1991;30:405-408.|
|2.||Stolk MF, van Erpecum KJ, Koppeschaar HP, de Bruin WI, Jansen JB, Lamers CB, van Berge Henegouwen GP. Postprandial gall bladder motility and hormone release during intermittent and continuous subcutaneous octreotide treatment in acromegaly. Gut. 1993;34:808-813. [PubMed] [DOI]|
|3.||Grimaldi C, Darcourt J, Harris AG, Lebot E, Lapalus F, Delmont J. Cholescintigraphic study of effect of somatostatin analog, octreotide, on bile secretion and gallbladder emptying in normal subjects. Dig Dis Sci. 1993;38:1718-1721. [PubMed] [DOI]|
|4.||Binmoeller KF, Dumas R, Harris AG, Delmont JP. Effect of somatostatin analog octreotide on human sphincter of Oddi. Dig Dis Sci. 1992;37:773-777. [PubMed]|
|5.||Milenov K, Rakovska A, Kalfin R, Mantovani P. Effect of somatostatin on the canine gallbladder motility. Neuropeptides. 1990;17:75-80. [PubMed] [DOI]|
|6.||Johnson AG, Marshall CE, Wilson IA. Effects of some drugs and peptide hormones on the responsiveness of the rabbit isolated gall-bladder to cholecystokinin. J Physiol. 1982;332:415-425. [PubMed] [DOI]|
|7.||Gullo L, Bolondi L, Scarpignato C, Priori P, Casanova P, Labò G. Effect of somatostatin and thyrotropin-releasing hormone on cholecystokinin-induced gallbladder emptying. Dig Dis Sci. 1986;31:1345-1350. [PubMed] [DOI]|
|8.||Sievert CE, Potter TJ, Levine AS, Morley JE, Silvis SE, Vennes JA. Effect of bombesin and gastrin-releasing peptide on canine sphincter of Oddi. Am J Physiol. 1988;254:G361-G365. [PubMed]|
|9.||Lin TM, Tust RH. Action of somatostatin on choledochal sphincter, gall-bladder and bile flow in rabbits. Federation Proc. 1997;36:557-558.|
|10.||Adami GF, Leandri R, Sarles JC. [Effect of somatostatin on the rabbit Oddi's sphincter in vivo. Interrelation of somatostatin and cholecystokinin]. Gastroenterol Clin Biol. 1986;10:108-111. [PubMed]|
|11.||Ahrendt SA, Ahrendt GM, Lillemoe KD, Pitt HA. Effect of octreotide on sphincter of Oddi and gallbladder motility in prairie dogs. Am J Physiol. 1992;262:G909-G914. [PubMed]|